Wear-debris powders of cobalt-chromium-molybdenum (CoCrMo) and titaniu
m-aluminum-vanadium (TiAlV) alloys, which are widely used for orthoped
ic implants leg, hip and knee prostheses), were tested for carcinogeni
c activity following intraarticular administration (20 mg/rat) to grou
ps of 44 male Fischer-344 rats (Charles River Breeding Laboratories, N
orth Wilmington, MA). Control groups received similar intraarticular i
njections of either a noncarcinogen (manganese powder, negative contro
l rats) or a potent carcinogen (nickel subsulfide powder, positive con
trol rats). The experimental groups of 8-12 rats were observed for 24
months after injection. No local tumors developed at the injection sit
e in the negative control rats or in rats that received the CoCrMo or
TiAlV powders; poorly differentiated or pleomorphic sarcomas developed
at the injection site in 10 of the 12 positive control rats that were
treated with nickel subsulfide. Incidences of primary tumors distant
from the injection site did not differ significantly among the experim
ental groups. This study shows that, under experimental conditions, an
y carcinogenic activity of CoCrMo or TiAlV wear-debris powders is weak
in comparison to nickel subsulfide. Based on this study and observati
ons in other laboratories, intraarticular administration of test mater
ials to rats provides a practical, reliable, and biologically relevant
method for carcinogenesis testing of biomaterials used for orthopedic
implants.